Diligence memo · auto-generated · as of July 2, 2026
Celsee Diagnostics, Inc.
Celsee Diagnostics, Inc. looks under-valued against its niche peers and is dormant on financing cadence.
Businessfiled
Celsee Diagnostics, Inc. operates in Medical Devices, based in ANN ARBOR.
Sub-sector tags: medical-devices.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Celsee Diagnostics, Inc. has raised $41M in disclosed capital across 9 recorded rounds, aggregated from public filings. Its latest round is modeled as Series B (a $15M–$40M round).
Largest single filing: $19M on 2018-11-13.
Most recent recorded round closed around 2019-12-12.
Valuation (modeled)modeled
Provath models Celsee Diagnostics, Inc. at approximately $135M (range $11M–$521M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Under-valued. Modeled value is 0.33× the median modeled value of Series B Medical Devices companies in 2019–2021 (10 peers) — value vs value, same stage and era.
Financing rhythm & timingmixed
Historic cadence: a new round about every 9 months.
Last raise 6.6 yr ago; this sector typically re-raises about every 16 months.
Silent for over 3× the sector's normal cadence.
The last round was 3.6× smaller than the prior — a bridge or down round.
Comparablesmixed
Capital scale ranks ahead of 93% of Medical Devices peers (233 compared).
Modeled value ranks above 91% of those peers.
Closest niche peers: Envision Diagnostics, Inc., Onkos Surgical, Inc., Regent Surgical Health Topco, L.P., Specific Diagnostics, Inc., Covenant Surgical Holdings L.P..
Peoplefiled
14 named people on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.